Tech Daily Utah
SEE OTHER BRANDS

Fresh news on science and technology in Utah

Tech Daily Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Utah.

Press releases published on May 14, 2025

Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results

Theriva™ Biologics Reports First Quarter 2025 Operational Highlights and Financial Results

- VCN-01 Achieves Primary Efficacy and Safety Endpoints for Pancreatic Ductal Adenocarcinoma in VIRAGE Phase 2b Clinical Trial - - Closed a public offering on May 8, 2025, raising the Company’s cash balance and extending its cash runway into the first …

Get In Early: Macrovey is LIVE on Netcapital!

Get In Early: Macrovey is LIVE on Netcapital!

Alpharetta, GA, May 14, 2025 (GLOBE NEWSWIRE) -- Industrial automation is at a turning point, and Macrovey is inviting forward-thinking investors to be part of what comes next. Now live on Netcapital, Macrovey is offering a unique opportunity to invest in …

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

Silo Pharma Advances PTSD Drug SPC-15 Toward First-in-Human Trial with Key Safety Study Initiated at Frontage Laboratories

SARASOTA, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has entered into an …

Foresight Collaborates with a Leading Global Tier-One Automotive Supplier to Enhance Bus Safety with Advanced 3D Perception Technology

Foresight Collaborates with a Leading Global Tier-One Automotive Supplier to Enhance Bus Safety with Advanced 3D Perception Technology

The parties will engage in a POC project to improve urban transit safety through precision curb detection system Ness Ziona, Israel, May 14, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), …

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month

New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effective, …

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

Newly granted patent is part of the expanding intellectual property portfolio directed to: -generating novel and selective Wnt surrogate molecules with potentially broad therapeutic utility and -incorporating novel discoveries related to requirements for …

Inuvo to Present at Ladenburg Thalmann Technology Innovation Expo on May 21

Inuvo to Present at Ladenburg Thalmann Technology Innovation Expo on May 21

LITTLE ROCK, Ark., May 14, 2025 (GLOBE NEWSWIRE) -- Inuvo, Inc. (NYSE American: INUV), a leading provider of artificial intelligence AdTech solutions, announced today that it will be participating in the Ladenburg Thalmann Innovation EXPO25, to be held on …

NETSOL Technologies Reports Third Quarter Fiscal 2025 Results

NETSOL Technologies Reports Third Quarter Fiscal 2025 Results

Total net revenues for Q3’25 increased by 13%, reaching $17.5 million, when compared with Q3’24. Total service revenue increased 24% in Q3’25, reaching $9.7 million, when compared with Q3,’24. Total subscription (SaaS and Cloud) and support revenues …

Brag House Continues Action to Protect Stockholders Against Potential Illegal Naked Short Selling

Brag House Continues Action to Protect Stockholders Against Potential Illegal Naked Short Selling

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (NASDAQ: TBH) (“Brag House” or the “Company”), the premier Gen Z engagement platform that operates at the intersection of gaming, college sports, and social interaction, today announced …

iPower Enhances SuperSuite Supply Chain Capabilities with “Made in USA” Module

iPower Enhances SuperSuite Supply Chain Capabilities with “Made in USA” Module

RANCHO CUCAMONGA, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and data-driven ecommerce services provider and online retailer, today announced the launch of a new strategic initiative under its …

Ethical Web AI submits AI Vault on AWS Marketplace for Enterprises to Purchase and Install

Ethical Web AI submits AI Vault on AWS Marketplace for Enterprises to Purchase and Install

NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) --  Bubblr Inc., d/b/a Ethical Web AI. (OTCQB: BBLR) - A frontrunner in enterprise-specific generative AI has submitted AI Vault to become publicly available on AWS Marketplace. AI Vault is Ethical Web AI's unique …

American Rebel Beer Announces Sponsorship of Losers Bar & Grill Midtown Legendary Parking Lot Concert Series

American Rebel Beer Announces Sponsorship of Losers Bar & Grill Midtown Legendary Parking Lot Concert Series

Surprise Guests Morgan Wallen, Gabby Barrett and Jamey Johnson Join Ernest, Chandler Walters, Cody Lohden, and Rhys Rutherford for First 2025 Concert Nashville, TN, May 14, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American …

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

UPDATE -- Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYN™ Gene Therapy to Treat Wounds in Painful Skin Disorder

- ZEVASKYN, the first and only cell-based gene therapy for patients with recessive dystrophic epidermolysis bullosa (RDEB), now commercially available in the U.S. - - Ann …

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights

Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025 Data presented at recent congresses reinforces the potential …

OxyCon Returns: The Flagship Web Scraping Conference Opens 2025 Registration

OxyCon Returns: The Flagship Web Scraping Conference Opens 2025 Registration

VILNIUS, Lithuania, May 14, 2025 – Leading web intelligence collection platform Oxylabs announces registration start for the year's main event. OxyCon 2025, the annual free conference uniting industry experts from all over the world, is set for October 1. …

Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing

Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing

IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration (FDA) cleared direct-to-consumer (DTC) test for celiac disease genetics, today announced a commercial …

INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference

INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference

BOCA RATON, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announces that the Company will be …

Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models

Channel Therapeutics Announces Positive Efficacy Results for the Treatment of Eye Pain Using its NaV1.7 Inhibitor in Multiple Preclinical In Vivo Models

FREEHOLD, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, today announced that it has achieved its …

NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference

NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference

NAARDEN, The Netherlands and MIAMI, May 14, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update

KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update

-- Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data anticipated in 3Q 2025 -- -- Cash resources of $42.2 million as of March 31, 2025, expected to fund operations into 1Q 2026 -- …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service